<DOC>
	<DOCNO>NCT02408302</DOCNO>
	<brief_summary>Currently Midazolam sedation standard care minor invasive procedure pediatric patient ; use restrict two route administration purpose oral intranasal . A third route administration ( buccal ) test approved seizure management . In investigator ' study researcher investigate buccal route administration versus oral intranasal administration sedation . The investigator ' hypothesis buccal route administration convenient intranasal well absorbed oral .</brief_summary>
	<brief_title>Buccal Midazolam Versus Nasal Oral Midazolam Sedation Minor Invasive Procedures Children</brief_title>
	<detailed_description />
	<mesh_term>Midazolam</mesh_term>
	<criteria>age 5 month 6 year . need undergo minimal invasive procedure require light sedation . ASA ( American Society Anesthesiologists ) III parent read , understand sign inform consent form patient life threatening condition . patient respiratory cardiac chronic illness ASA III . patient traumatic injury nose oral cavity . patient would take drug route pick randomized way .</criteria>
	<gender>All</gender>
	<minimum_age>5 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>